Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047

Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy

(2017) Ying Xie et al.   JOURNAL OF CONTROLLED RELEASE

Polyamine–DNA interactions and development of gene delivery vehicles

(2016) T. J. Thomas et al.   AMINO ACIDS

Targeting polyamine metabolism for cancer therapy and prevention

(2016) T. R. Murray-Stewart et al.   BIOCHEMICAL JOURNAL

Antibiotic-containing polymers for localized, sustained drug delivery

(2014) Nicholas D. Stebbins et al.   ADVANCED DRUG DELIVERY REVIEWS

Bioreducible Polycations in Nucleic Acid Delivery: Past, Present, and Future Trends

(2014) David Oupický et al.   MACROMOLECULAR BIOSCIENCE

Self-Immolative Polycations as Gene Delivery Vectors and Prodrugs Targeting Polyamine Metabolism in Cancer

(2014) Yu Zhu et al.   MOLECULAR PHARMACEUTICS

Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention

(2013) Valentina Battaglia et al.   AMINO ACIDS

Recent advances in delivery of drug–nucleic acid combinations for cancer treatment

(2013) Jing Li et al.   JOURNAL OF CONTROLLED RELEASE

Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism

(2013) T. Murray-Stewart et al.   MOLECULAR CANCER THERAPEUTICS

Synthesis and characterization of poly(antioxidant β-amino esters) for controlled release of polyphenolic antioxidants

(2012) Paritosh P. Wattamwar et al.   Acta Biomaterialia

Synthesis of Bisethylnorspermine Lipid Prodrug as Gene Delivery Vector Targeting Polyamine Metabolism in Breast Cancer

(2012) Yanmei Dong et al.   MOLECULAR PHARMACEUTICS

Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer

(2011) R. R. Olsen et al.   MOLECULAR CANCER RESEARCH

Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program

(2011) Malcolm A. Smith et al.   PEDIATRIC BLOOD & CANCER

Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047

(2010) Helena Cirenajwis et al.   ANTI-CANCER DRUGS

Polymers for Drug Delivery Systems

(2010) William B. Liechty et al.   Annual Review of Chemical and Biomolecular Engineering

Polyamine catabolism and disease

(2009) Robert A. Casero et al.   BIOCHEMICAL JOURNAL

A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047

(2009) Wen-Lin Kuo et al.   BMC Medicine

The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer

(2009) K. Dredge et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Modulation of cellular function by polyamines

(2009) Kazuei Igarashi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells

(2008) Amy Hacker et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Nuclear localization of human spermine oxidase isoforms - possible implications in drug response and disease etiology

(2008) Tracy Murray-Stewart et al.   FEBS Journal